Fexofenadine-induced urticaria.
Fexofenadine-induced urticaria.
复制标题
DOI：
10.5021/ad.2011.23.s3.s329
复制
发表时间：
2011-12
影响因子：
1.6
通讯作者：
Choi HY
中科院分区：
文献类型：
--
作者：
Lee SW;Byun JY;Choi YW;Myung KB;Choi HY
非索非那定（Allegra® 180）是第二代抗组胺药。它被广泛用作抗过敏药物，可抑制组胺介导的各种过敏反应。少数情况下，H1-抗组胺药引起的荨麻疹已报告。在此，我们报告一例罕见的非索非那定引起的荨麻疹，证实了点刺试验，口服激发试验，流式细胞仪辅助嗜碱性粒细胞活化试验。
Fexofenadine (Allegra® 180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine-induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-basophil activation test.